Table 2 Baseline clinical characteristics

Age (years)

71.8 ± 1.8

69.3 ± 2.3

0.14

Weight (kg)

79.9 ± 2.7

87.2 ± 4.7

0.03

BMI kg/m²

28.8 ± 1.1

29.7 ± 1.3

0.36

Number of co-morbidities^a

0.9 ± 0.2

1.5 ± 0.2

0.81

Number of medications

1.1 ± 0.3

1.5 ± 1.1

0.91

SBP (mmHg)

137 ± 2

139 ± 4

0.18

DBP (mmHg)

74 ± 3

74 ± 1

0.11

Gleason score

7.6 ± 0.3

8.2 ± 0.2

0.42

 Localised (n)

9

8

0.36

 Biochemical recurrence (n)

3

3

 Metastatic (n)

0

2

Previous radiotherapy (n)

8

5

0.39

Previous ADT (n)

0

2

0.26

Lean body mass (kg)

53.1 ± 1.2

54.5 ± 2.2

0.16

LBM (% body weight)

66.5 ± 1.8

63.2 ± 2.0

0.68

Fat mass (kg)

24.2 ± 2.1

29.9 ± 3.2

0.12

Extracellular water (L)

19.0 ± 0.6

19.8 ± 0.9

0.05

BCM (kg)

34.1 ± 1.0

34.7 ± 1.3

0.58

Testosterone (nmol/L)

16.1 ± 1.1

12.5 ± 0.8

0.02

LH (mIU/mL)

7.0 ± 0.7

6.3 ± 0.7

0.70

PSA (ng/mL)

10.3 ± 3.3

7.7 ± 1.3

0.08

Step count (number)

40172 ± 8502

28838 ± 5377

0.14

Light physical activity (h)

5.9 ± 1.6

7.9 ± 2.5

0.09

Moderate physical activity (h)

3.9 ± 1.8

3.3 ± 1.4

0.93

High physical activity (h)

0.1 ± 0.1

0.5 ± 0.3

0.05